Related Experiment Videos
Pulmonary Langerhans' cell histiocytosis
1Division of Pulmonary and Critical Care and Internal Medicine, Mayo Clinic and Foundation, 200 First Street Southwest, Rochester, MN, 55905, USA.
Clinics in Chest Medicine
|August 28, 2004
Summary
Pulmonary Langerhans' cell histiocytosis (PLCH) is a rare lung disease primarily affecting adult smokers. This review covers recent advancements in understanding PLCH, a form of Langerhans' cell histiocytosis.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Pulmonary Langerhans' cell histiocytosis (PLCH) is an uncommon interstitial lung disease.
- It is part of the Langerhans' cell histiocytosis (LCH) spectrum, involving uncontrolled proliferation of Langerhans cells.
- PLCH predominantly affects adult cigarette smokers and can be the sole organ manifestation of LCH.
Purpose of the Study:
- To summarize recent advances in the understanding of Pulmonary Langerhans' cell histiocytosis (PLCH).
- To provide an updated overview of current knowledge regarding PLCH.
Main Methods:
- Review of recent scientific literature and clinical studies on PLCH.
- Synthesis of current understanding of LCH spectrum and pulmonary involvement.
Main Results:
- PLCH is a significant cause of interstitial lung disease in adults.
- While LCH is more common in children, pulmonary involvement is more frequent in adults.
- PLCH often presents as the only organ affected in adult LCH cases.
Conclusions:
- PLCH remains an important consideration in the differential diagnosis of interstitial lung disease in smokers.
- Further research is needed to fully elucidate the pathogenesis and optimal management of PLCH.
- Understanding the LCH spectrum is crucial for diagnosing and managing PLCH.